Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
808.00    -10.00 (-1.22%)
Bid:
811.00
Ask:
813.00
Spread: 2.00 (0.247%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Savills Announces Succession Plan

29 Apr 2025 07:00

RNS Number : 5009G
Savills PLC
29 April 2025
 

 

Stock Exchange Announcement

29 April 2025

 

SAVILLS PLC

("Savills" or the "Group")

Savills Announces Succession Plan

 

The Board of Savills today announces that Mark Ridley will retire as Group Chief Executive at the end of 2025 after a 29 year career at Savills, seven of them as Group Chief Executive, and 41 years in the industry. Mark will be succeeded by Simon Shaw, currently Group Chief Financial Officer of Savills, effective 1 January 2026.

 

Simon joined Savills in March 2009 as Group Chief Financial Officer working alongside the Group Chief Executive, with responsibility for all financial matters, significant M&A, Technology and Investor Relations. He is a member of the Group and Regional Executive Boards (Asia Pacific/EMEA/UK/North America) and further is responsible to the Board for Savills Investment Management. Simon is also Chair of Grosvenor Hill Ventures, Savills proprietary private equity investment business, which is focused on investing in "Proptech" opportunities.

The selection of a new Group Chief Financial Officer will now commence.

 

Stacey Cartwright, Chair of Savills plc, comments: 

 

"Under Mark's leadership, Savills has achieved significant growth and stronger balance, both geographically and by service line. He has successfully steered the business through BREXIT and its aftermath and the pandemic years, and more recently global macroeconomic and geopolitical headwinds, navigating these very significant challenges whilst growing the business at the same time.

 

"We are all delighted that, following his retirement at the end of 2025, Mark will remain available in a senior advisory role supporting the business.

 

"Having used an external adviser to consider internal and external candidates, the Board has decided to appoint Simon Shaw, current Group Chief Financial Officer, as Group Chief Executive effective 1 January 2026, following Mark's retirement from the Board on 31 December 2025. Simon is a highly experienced and respected senior Savills Executive who will lead the Group's strong management team through the next phase of the development of the Savills business worldwide. The Board and I very much look forward to working with him as Group Chief Executive."

 

 

 

For more information, please call: 

 

Elizabeth Snow, Teneo Elizabeth.Snow@teneo.com Tel: +44 (0) 791 254 0246

Victoria Buchanan, Savills vbuchanan@savills.com Tel: +44 7870 999653

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFFRSIITFIE
Date   Source Headline
1st Jun 202611:29 amRNSTotal Voting Rights
22nd May 202610:09 amRNSDirector/PDMR Shareholding
14th May 202612:41 pmRNSResult of AGM
13th May 20264:16 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Statement
12th May 20263:41 pmRNSDirector/PDMR Shareholding
7th May 20263:39 pmRNSDirector Declaration
29th Apr 20263:04 pmRNSReplacement - Director/PDMR Shareholding
29th Apr 20261:23 pmRNSDirector/PDMR Shareholding
28th Apr 20261:58 pmRNSDirector/PDMR Shareholding
13th Apr 20265:24 pmRNSHolding(s) in Company
13th Apr 20262:10 pmRNSDirector/PDMR Shareholding
7th Apr 20264:03 pmRNSAnnual Report and AGM Notice
1st Apr 202610:00 amRNSTotal Voting Rights
31st Mar 202612:55 pmRNSDirector/PDMR Shareholding
26th Mar 20268:57 amRNSDirector/PDMR Shareholding
24th Mar 202611:02 amRNSDirector/PDMR Shareholding
23rd Mar 20269:27 amRNSDirector/PDMR Shareholding
18th Mar 20263:47 pmRNSDirector/PDMR Shareholding
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
13th Mar 20261:34 pmRNSDirector/PDMR Shareholding
13th Mar 20261:32 pmRNSDirector/PDMR Shareholding
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:08 amRNSFinal Results
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
5th Mar 20265:00 pmRNSHolding(s) in Company
2nd Mar 20269:11 amRNSTotal Voting Rights
25th Feb 202611:14 amRNSHolding(s) in Company
11th Feb 20264:07 pmRNSDirector/PDMR Shareholding
4th Feb 20265:29 pmRNSHolding(s) in Company
2nd Feb 20265:32 pmRNSTotal Voting Rights
19th Jan 20268:30 amRNSDirectorship change
15th Jan 20267:00 amRNSYear End Trading Update
13th Jan 20265:40 pmRNSDirector/PDMR Shareholding
13th Jan 202612:59 pmRNSHolding(s) in Company
2nd Jan 20263:00 pmRNSTotal Voting Rights
11th Dec 20252:00 pmRNSDirector/PDMR Shareholding
1st Dec 20259:49 amRNSTotal Voting Rights
11th Nov 20254:58 pmRNSDirector/PDMR Shareholding
3rd Nov 202512:32 pmRNSTotal Voting Rights
13th Oct 20251:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.